002020.SZ
京新药业
SZSE · Healthcare · C 制造业 · CN
CNY 12.69
−3.72%Margins
Gross margin
50.9%
EBITDA margin
28.5%
EBIT margin
21.4%
Net margin
18.8%
FCF margin
15.2%
12.5%
Return on equity
9.4%
Return on assets
13.8%
Return on invested capital
0.50x
Asset turnover
CNY 800.3M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026